s******f
发帖数: 3984 | | M*****g
发帖数: 3145 | | f**********g
发帖数: 2252 | 3 Idenix Announces Data Presentations at the 61st Annual Meeting of the
American Association for the Study of Liver Diseases (AASLD)
Friday 10/01/2010 9:55 AM ET - Pr Newswire
Related Companies
Symbol Last %Chg
IDIX 3.65 7.35%
As of 10:56 AM ET 10/6/10
Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX), a biopharmaceutical company
engaged in the discovery and development of drugs for the treatment of human
viral diseases, today announced that three abstracts have been accepted for
presentation at the 61st Annual Meeting of the American Association for the
Study of Liver Diseases (AASLD, October 29-November 2, 2010 in Boston,
Massachusetts). The abstracts being presented are on three of the company's
hepatitis C clinical programs: IDX184, IDX320 and IDX375. Full abstracts can
now be viewed at the AASLD website at www.aasld.org.
The accepted abstracts are as follows:
Lalezari, et al, "A Phase IIa Study of IDX184 in Combination with Pegylated
Interferon (PegIFN) and Ribavirin (RBV) in Treatment-Naïve HCV Genotype
1-Infected Subjects" will be featured as an oral presentation on Sunday,
October 31st at 3:45 p.m.
Reesink, et al, "Antiviral Activity, Safety and Pharmacokinetics of IDX320,
a Novel Macrocyclic HCV Protease Inhibitor, in a 3-Day Proof-of-Concept
Study in Patients with Chronic Hepatitis C" will be presented in a late-
breaking poster session on Monday, November 1st between 8:00 a.m. - 5:30 p.m
.
Bruijne, et al, "Phase I Study in Healthy Volunteers and Patients with
IDX375, a Novel Non-Nucleoside HCV Polymerase Inhibitor" will be presented
in a poster session on Tuesday, November 2nd between 7:00 a.m. - 12:00 p.m.
About Idenix
Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is
a biopharmaceutical company engaged in the discovery and development of
drugs for the treatment of human viral diseases. Idenix's current focus is
on the treatment of infections caused by hepatitis C virus. For further
information about Idenix, please refer to www.idenix.com. | s******f
发帖数: 3984 | | f**********g
发帖数: 2252 | 5 Not yet. It still needs time to break out 4, then the next target will be 5.
【在 s******f 的大作中提到】
: cross 4 now
|
|
